BOLTON SECURITIES CORPORATION’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$491K Buy
+3,213
New +$493K 0.02% 558
2025
Q3
$426K Buy
+3,323
New +$405K 0.02% 555
2025
Q1
$370K Buy
+3,323
New +$354K 0.02% 553

Other funds holding NVS

BOLTON SECURITIES CORPORATION's NVS Position: Q1 2026 in Review

BOLTON SECURITIES CORPORATION opened a new position in Novartis (NVS) in Q1 2026: 3,213 shares worth $491K. The stake represents 0.02% of the portfolio and ranks #558 among its holdings. This is a return to the name: BOLTON SECURITIES CORPORATION previously reported a position in NVS as recently as Q3 2025.

BOLTON SECURITIES CORPORATION first reported a position in NVS in Q1 2025 and has held it in 3 quarters since. 1,612 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • BOLTON SECURITIES CORPORATION held 3,213 shares of Novartis worth $491K as of Q1 2026.
  • Novartis was a new BOLTON SECURITIES CORPORATION position in Q1 2026.
  • Novartis made up 0.02% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2026, its #558 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Novartis in Q1 2025 and has held it in 3 quarters since.
  • 1,612 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2026, filed 12 Nov 2026.